A Study Comparing ABBV-706 With Standard Treatment in People With Small Cell Lung Cancer

Full Title

A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 versus Standard of Care in Subjects with Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Jessica Ross’s office at 646-608-4422. 

Protocol
26-269
Phase
Phase III (phase 3)
Disease Status
Relapsed or Refractory
Investigator
Jessica Ross
Co-Investigators
Charles M. Rudin
Diseases
Lung Cancer › Lung Cancer, Small Cell
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07365241
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description